Shih‐Ching Chang

5.5k total citations
148 papers, 4.3k citations indexed

About

Shih‐Ching Chang is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Shih‐Ching Chang has authored 148 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Oncology, 61 papers in Pathology and Forensic Medicine and 59 papers in Surgery. Recurrent topics in Shih‐Ching Chang's work include Colorectal Cancer Treatments and Studies (61 papers), Genetic factors in colorectal cancer (60 papers) and Colorectal Cancer Surgical Treatments (41 papers). Shih‐Ching Chang is often cited by papers focused on Colorectal Cancer Treatments and Studies (61 papers), Genetic factors in colorectal cancer (60 papers) and Colorectal Cancer Surgical Treatments (41 papers). Shih‐Ching Chang collaborates with scholars based in Taiwan, United States and South Korea. Shih‐Ching Chang's co-authors include Jen-Kou Lin, Shung-Haur Yang, Huann-Sheng Wang, Yuan‐Tzu Lan, Wei-Shone Chen, Jeng‐Kai Jiang, Tzu-Chen Lin, Chun‐Chi Lin, Shih‐Hwa Chiou and Pei-Ching Lin and has published in prestigious journals such as Gastroenterology, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Shih‐Ching Chang

144 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih‐Ching Chang Taiwan 37 2.8k 1.2k 1.1k 1.1k 1.0k 148 4.3k
Hyojin Kim South Korea 33 2.2k 0.8× 1.1k 0.9× 731 0.7× 395 0.4× 978 1.0× 178 4.3k
Jean‐Christophe Sabourin France 31 2.5k 0.9× 845 0.7× 737 0.7× 767 0.7× 680 0.7× 126 4.2k
Gennaro Galizia Italy 43 2.8k 1.0× 1.2k 1.0× 1.3k 1.2× 731 0.7× 910 0.9× 140 5.2k
Rondell P. Graham United States 34 2.2k 0.8× 1.3k 1.1× 1.8k 1.6× 670 0.6× 930 0.9× 227 5.0k
Dongfeng Tan United States 37 1.6k 0.6× 1.9k 1.6× 772 0.7× 543 0.5× 897 0.9× 124 4.0k
Hee Cheol Kim South Korea 37 3.2k 1.1× 933 0.8× 2.1k 1.9× 700 0.6× 490 0.5× 269 4.7k
Yoshiaki Inayama Japan 35 1.2k 0.4× 1.2k 1.0× 1.0k 0.9× 440 0.4× 547 0.5× 194 3.9k
Xavier Sagaert Belgium 35 2.2k 0.8× 1.4k 1.2× 929 0.8× 1.4k 1.3× 992 1.0× 118 4.9k
Masayuki Ohue Japan 38 3.0k 1.1× 1.0k 0.9× 2.8k 2.5× 490 0.4× 627 0.6× 317 5.8k
Aziza Nassar United States 31 1.3k 0.5× 709 0.6× 858 0.8× 579 0.5× 856 0.9× 146 3.3k

Countries citing papers authored by Shih‐Ching Chang

Since Specialization
Citations

This map shows the geographic impact of Shih‐Ching Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Ching Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Ching Chang more than expected).

Fields of papers citing papers by Shih‐Ching Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih‐Ching Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Ching Chang. The network helps show where Shih‐Ching Chang may publish in the future.

Co-authorship network of co-authors of Shih‐Ching Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Shih‐Ching Chang. A scholar is included among the top collaborators of Shih‐Ching Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih‐Ching Chang. Shih‐Ching Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Shih‐Ching, et al.. (2025). The influence of neoadjuvant chemotherapy cycles on surgical complications in metastatic colon cancer. The American Journal of Surgery. 252. 116727–116727. 1 indexed citations
2.
Lin, Wen-Ling, Wei‐Shone Chen, Jeng‐Kai Jiang, et al.. (2024). The survival outcome differs between left-sided colon cancer and middle/low rectal cancer after colorectal hepatic metastasectomy. Journal of Gastrointestinal Surgery. 28(8). 1250–1258. 1 indexed citations
3.
Chang, Shih‐Ching, et al.. (2023). Protective loop ileostomy or colostomy? A risk evaluation of all common complications. Annals of Coloproctology. 40(6). 580–587. 3 indexed citations
4.
Lo, Chung‐Ming, Jen‐Kou Lin, Tzu‐Chen Lin, et al.. (2023). Modeling the survival of colorectal cancer patients based on colonoscopic features in a feature ensemble vision transformer. Computerized Medical Imaging and Graphics. 107. 102242–102242. 22 indexed citations
5.
Lin, Hung‐Hsin, et al.. (2022). The impact of inflammatory markers on prognosis of stage II colon cancers depends on tumour sidedness. ANZ Journal of Surgery. 93(1-2). 182–195. 3 indexed citations
6.
Lin, Hung‐Hsin, Sheng‐Chieh Huang, Chun‐Chi Lin, et al.. (2022). Clinical outcome of local treatment and radical resection for pT1 rectal cancer. International Journal of Colorectal Disease. 37(8). 1845–1851. 4 indexed citations
7.
Chen, Hung-Ming, Chun‐Chi Lin, Wei‐Shone Chen, et al.. (2021). Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer. International Journal of Molecular Sciences. 22(13). 6940–6940. 30 indexed citations
8.
Fang, Wen-Liang, Ming‐Huang Chen, Kuo‐Hung Huang, et al.. (2019). Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array. Clinical Epigenetics. 11(1). 154–154. 11 indexed citations
9.
Lee, Yu‐Ting, Chia‐Jen Liu, Yu‐Wen Hu, et al.. (2015). Incidence of Second Primary Malignancies Following Colorectal Cancer. Medicine. 94(26). e1079–e1079. 27 indexed citations
10.
Lin, Jen-Kou, Pei-Ching Lin, Chien-Hsing Lin, et al.. (2014). Clinical Relevance of Alterations in Quantity and Quality of Plasma DNA in Colorectal Cancer Patients: Based on the Mutation Spectra Detected in Primary Tumors. Annals of Surgical Oncology. 21(S4). 680–686. 53 indexed citations
11.
Weng, Shih‐Feng, et al.. (2013). Role for gender in colorectal cancer risk: a Taiwan population-based study. International Journal of Colorectal Disease. 28(7). 1001–1008. 13 indexed citations
12.
Lin, Hung‐Hsin, Chun‐Chi Lin, Yuan‐Tzu Lan, et al.. (2012). Clinicopathological Differences between Mucinous Adenocarcinoma and Signet-Ring Cell Carcinoma in the Colorectum. 23(4). 151–159. 1 indexed citations
13.
Chang, Shih‐Ching. (2012). Clinical features and management of primary colonic lymphoma. Formosan Journal of Surgery. 45(3). 73–77. 8 indexed citations
14.
Chang, Shih‐Ching, Yuan‐Tzu Lan, Huann‐Sheng Wang, et al.. (2011). The Clinicopathologic Features and Outcome of Patients with Gastrointestinal Stromal Tumors in Colorectal Region. 22(4). 115–121. 1 indexed citations
16.
Hwang, Wei‐Lun, Muh‐Hwa Yang, Hsin‐Yi Lan, et al.. (2011). SNAIL Regulates Interleukin-8 Expression, Stem Cell–Like Activity, and Tumorigenicity of Human Colorectal Carcinoma Cells. Gastroenterology. 141(1). 279–291.e5. 255 indexed citations
17.
Chang, Shih‐Ching, Tzu‐Chen Lin, Shung-Haur Yang, et al.. (2010). The Risk Factors of Anastomotic Leakage and Influence of Fecal Diversion after Resection of Rectal Cancer. 21(1). 9–16. 2 indexed citations
18.
Chang, Shih‐Ching, Tzu‐Chen Lin, Wei‐Shone Chen, et al.. (2008). Long Term Outcome of Local Excision for T1-2 Rectal Cancer. 19(3). 78–86. 1 indexed citations
19.
Lin, Jen-Kou, Shih‐Ching Chang, Huann-Sheng Wang, et al.. (2006). Distinctive clinicopathological features ofKi-ras mutated colorectal cancers. Journal of Surgical Oncology. 94(3). 234–241. 15 indexed citations
20.
Chang, Shih‐Ching, et al.. (2005). Relationship between genetic alterations and prognosis in sporadic colorectal cancer. International Journal of Cancer. 118(7). 1721–1727. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026